These findings provide a deeper understanding of how HMOX1 dysregulation may contribute to the development and progression of DLE, paving the way for future investigations and potentially guiding the development of targeted therapeutic approaches. This evidence concerns the gene HMOX1 and discoid lupus erythematosus.